Cliff Asness's TXG Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.58 M shares of 10x Genomics, Inc. (TXG) worth $41.86 M, representing 0.02% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TXG, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 2.93 M shares. Largest reduction occurred in Q3 2025, reducing 1.41 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -147,941 | Reduce 5.43% | 2.58 M | $16.23 |
| Q3 2025 | -1.41 M | Reduce 34.10% | 2.73 M | $11.54 |
| Q2 2025 | +2.93 M | Add 241.28% | 4.14 M | $11.58 |
| Q1 2025 | +695,227 | Add 134.42% | 1.21 M | $8.73 |
| Q4 2024 | -211,830 | Reduce 29.06% | 517,202 | $14.36 |
| Q3 2024 | +413,852 | Add 131.31% | 729,032 | $22.46 |
| Q2 2024 | +219,945 | Add 230.95% | 315,180 | $19.45 |
| Q1 2024 | +46,710 | Add 96.26% | 95,235 | $37.53 |
| Q4 2023 | +37,564 | Add 342.71% | 48,525 | $55.96 |
| Q3 2023 | -2,850 | Reduce 20.64% | 10,961 | $41.25 |
| Q2 2023 | +13,811 | New Buy | 13,811 | $55.84 |
| Q2 2021 | -27,658 | Sold Out | 0 | $0.00 |
| Q1 2021 | -27,998 | Reduce 50.31% | 27,658 | $177.42 |
| Q4 2020 | +55,656 | New Buy | 55,656 | $141.60 |
Cliff Asness's 10x Genomics Investment FAQs
Cliff Asness first purchased 10x Genomics, Inc. (TXG) in Q4 2020, acquiring 55,656 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held 10x Genomics, Inc. (TXG) for 14 quarters since Q4 2020.
Cliff Asness's largest addition to 10x Genomics, Inc. (TXG) was in Q2 2025, adding 4,137,801 shares worth $47.92 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,579,051 shares of 10x Genomics, Inc. (TXG), valued at approximately $41.86 M.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 0.02% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in 10x Genomics, Inc. (TXG) was 4,137,801 shares, as reported at the end of Q2 2025.